Phibro Animal Health (PAHC) Finished Goods (2013 - 2026)

Phibro Animal Health's Finished Goods history runs 14 years deep, the most recent figure standing at $318.0 million for Q1 2026.

• In Q1 2026, Finished Goods rose 17.67% year-over-year to $318.0 million; the TTM figure through Mar 2026 stood at $318.0 million (up 17.67% YoY), while the FY2025 annual figure was $253.8 million, up 49.69% from the prior year.
• Finished Goods was $318.0 million for Q1 2026 at Phibro Animal Health, up from $309.7 million in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $318.0 million in Q1 2026 to a low of $151.8 million in Q1 2022.
• Historically, Finished Goods has averaged $209.9 million across 5 years, with a median of $180.5 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Finished Goods slipped 3.0% in 2024, then soared 63.76% in 2025.
• A 5-year view of Finished Goods shows it stood at $172.4 million in 2022, then rose by 7.05% to $184.6 million in 2023, then surged by 38.16% to $255.0 million in 2024, then gained by 21.43% to $309.7 million in 2025, then grew by 2.7% to $318.0 million in 2026.
• The last three Finished Goods figures came in at $318.0 million (Q1 2026), $309.7 million (Q4 2025), and $279.6 million (Q3 2025), per Business Quant data.